Atlas Trials

A Clinical Study of CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies

Clinical trial NCT04008524 · AVAILABLE

Trial details

NCT number
NCT04008524
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Relapsed and Refractory Hematological Malignancies

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.